Researchers sought to determine whether mosunetuzumab would have long-term efficacy in patients with follicular lymphoma.

One-third of patients with PSA levels below 0.2 ng/mL after radical prostatectomy have recurrent disease identifiable by PSMA PET. More than one-third of patients with PSA levels less than 0.5 ng/mL ...

HealthDay News — A high proportion of women seem to undergo mammography screening every year, despite recommendations for biennial screening, according to a research letter published online March 25 ...

Pembrolizumab improved progression-free survival, second progression-free survival, and overall survival. Adding pembrolizumab to concurrent chemoradiotherapy (CCRT) can improve survival outcomes in ...

Researchers sought to test the performance of a deep learning model system using longitudinal magnetic resonance imaging (MRI) in predicting early recurrence in patients with hepatocellular carcinoma.

Results from a meta-analysis suggest patients with resectable dMMR/MSI-H gastric cancer can forgo perioperative chemotherapy.

Data suggest that the United States had the second highest number of mesothelioma cases and the second highest number of deaths from mesothelioma in 2021. These data were published in Lung Cancer. For ...

Cancer drugs conferring low or no therapeutic benefits accounted for $6.7 billion in post-rebate Medicare spending in 2022.

Study reveals Medicaid and private insurance copay rates are similar for adults 50 years and older using portal messaging.

Our real-world findings indicate that most patients undergoing multiple lines of therapy experience persistent treatment refractoriness and low response rates,” the researchers wrote.

Strategies for helping the children of patients with cancer cope with their parent’s disease, treatment, and prognosis.

Researchers studied trends in survival following FDA approval of immune checkpoint inhibitors among patients with advanced Merkel cell carcinoma.